Urinary enterolactone associated with liver enzyme levels in US adults: National Health and Nutrition Examination Survey (NHANES)

British Journal of Nutrition

Volumn 114, Issue 1, 2015, Pages 91-97

  Xu, Cheng ^a,b   Liu, Qian ^a,b   Zhang, Qunwei ^c   Jiang, Zhao Yan ^d   Gu, Aihua ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cross sectional studies; Enterolactone; Liver enzymes; Phyto oestrogens

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; DAIDZEIN; ENTERODIOL; ENTEROLACTONE; EQUOL; GAMMA GLUTAMYLTRANSFERASE; GENISTEIN; O DESMETHYLANGOLENSIN; PHYTOESTROGEN; UNCLASSIFIED DRUG; 2,3-BIS(3'-HYDROXYBENZYL)BUTYROLACTONE; GAMMA BUTYROLACTONE; LIGNAN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENTEROLACTONE URINE LEVEL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER PROTECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; SEX DIFFERENCE; UNITED STATES; URINALYSIS; URINE LEVEL; VERY ELDERLY; YOUNG ADULT; ANALOGS AND DERIVATIVES; BLOOD; ENZYMOLOGY; LIVER; NUTRITION; STATISTICAL MODEL; URINE;

4-BUTYROLACTONE; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIGNANS; LIVER; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PHYTOESTROGENS; UNITED STATES;

EID: 84937633741     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451500149X     Document Type: Article

References (44)

1. Humfrey CD (1998) Phytoestrogens and human health effects: weighing up the current evidence. Nat Toxins 6, 51-59.
2. Younes M & Honma N (2011) Estrogen receptor beta. Arch Pathol Lab Med 135, 63-66.
3. Paterni I, Granchi C, Katzenellenbogen JA, et al. (2014) Estrogen receptors alpha (ERalpha) and beta (ERbeta): subtype-selective ligands and clinical potential. Steroids 90, 13-29.
4. Bar-El DS & Reifen R (2010) Soy as an endocrine disruptor: cause for caution? J Pediatr Endocrinol Metab 23, 855-861.
5. Bilal I, Chowdhury A, Davidson J, et al. (2014) Phytoestrogens and prevention of breast cancer: the contentious debate. World J Clin Oncol 5, 705-712.
6. Hwang YW, Kim SY, Jee SH, et al. (2009) Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr Cancer 61, 598-606.
7. Frankenfeld CL (2014) Cardiometabolic risk factors are associated with high urinary enterolactone concentration, independent of urinary enterodiol concentration and dietary fiber intake in adults. J Nutr 144, 1445-1453.
8. Struja T, Richard A, Linseisen J, et al. (2014) The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES. Eur J Nutr 53, 1371-1381.
9. Choi EJ & Kim GH (2009) Hepatoprotective effects of daidzein against 7,12-dimetylbenz[a]anthracene-induced oxidative stress in mice. Int J Mol Med 23, 659-664.
10. Mohamed Salih S, Nallasamy P, Muniyandi P, et al. (2009) Genistein improves liver function and attenuates nonalcoholic fatty liver disease in a rat model of insulin resistance. J Diabetes 1, 278-287.
11. Fan YJ, Rong Y, Li PF, et al. (2013) Genistein protection against acetaminophen-induced liver injury via its potential impact on the activation of UDP-glucuronosyltransferase and antioxidant enzymes. Food Chem Toxicol 55, 172-181.
12. National Health and Nutrition Examination Survey (2012) Questionnaires, datasets and related documentation: NHANES 1999-2010. http://www.cdc.gov/nchs/nhanes.htm (accessed 23 December 2014).
13. National Center for Health Statistics (2010) Hyattsville MCfDCaP. National Health and Nutrition Examination Survey 2001-2002 Lab Methods. http://www.cdc.gov/nchs/nhanes/nhanes2001-2002/lab-methods-01-02.htm
14. Engelhardt PF & Riedl CR (2008) Effects of one-year treatment with isoflavone extract from red clover on prostate, liver function, sexual function, and quality of life in men with elevated PSA levels and negative prostate biopsy findings. Urology 71, 185-190.
15. Barsalani R, Riesco E, Lavoie JM, et al. (2013) Effect of exercise training and isoflavones on hepatic steatosis in overweight postmenopausal women. Climacteric 16, 88-95.
16. Manonai J, Chittacharoen A, Udomsubpayakul U, et al. (2008) Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women. Menopause 15, 530-535.
17. Rietjens IM, Sotoca AM, Vervoort J, et al. (2013) Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks. Mol Nutr Food Res 57, 100-113.
18. Wang LQ (2002) Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr B Analyt Technol Biomed Life Sci 777, 289-309.
19. Cassidy A (2003) Potential risks and benefits of phytoestrogen-rich diets. Int J Vitam Nutr Res 73, 120-126.
20. Bottner M, Thelen P & Jarry H (2014) Estrogen receptor beta: tissue distribution and the still largely enigmatic physiological function. J Steroid Biochem Mol Biol 139, 245-251.
21. Vina J, Gambini J, Lopez-Grueso R, et al. (2011) Females live longer than males: role of oxidative stress. Curr Pharm Des 17, 3959-3965.
22. Bourque M, Dluzen DE & Di Paolo T (2012) Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease. Front Neuroendocrinol 33, 169-178.
23. Ming LG, Chen KM & Xian CJ (2013) Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J Cell Physiol 228, 513-521.
24. Yanagihara N, Zhang H, Toyohira Y, et al. (2014) New insights into the pharmacological potential of plant flavonoids in the catecholamine system. J Pharmacol Sci 124, 123-128.
25. Kurzer MS & Xu X (1997) Dietary phytoestrogens. Annu Rev Nutr 17, 353-381.
26. Fu Z, Zhang W, Zhen W, et al. (2010) Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology 151, 3026-3037.
27. Lim U & Song MA (2012) Dietary and lifestyle factors of DNA methylation. Methods Mol Biol 863, 359-376.
28. Hajirahimkhan A, Dietz BM & Bolton JL (2013) Botanical modulation of menopausal symptoms: mechanisms of action? Planta Med 79, 538-553.
29. Wong MC, Portmann B, Sherwood R, et al. (2007) The cytoprotective effect of alpha-tocopherol and daidzein against d-galactosamine-induced oxidative damage in the rat liver. Metabolism 56, 865-875.
30. Lockhat D, Katz SS, Lisbona R, et al. (1981) Oral contraceptives and liver disease. Can Med Assoc J 124, 993-999.
31. Belchetz PE (1994) Hormonal treatment of postmenopausal women. N Engl J Med 330, 1062-1071.
32. Pares A, Caballeria J, Bruguera M, et al. (1986) Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol 2, 33-42.
33. Loft S, Olesen KL & Dossing M (1987) Increased susceptibility to liver disease in relation to alcohol consumption in women. Scand J Gastroenterol 22, 1251-1256.
34. Norton R, Batey R, Dwyer T, et al. (1987) Alcohol consumption and the risk of alcohol related cirrhosis in women. Br Med J (Clin Res Ed) 295, 80-82.
35. Iimuro Y, Frankenberg MV, Arteel GE, et al. (1997) Female rats exhibit greater susceptibility to early alcohol-induced liver injury than males. Am J Physiol 272, G1186-G1194.
36. Grimbert S, Fisch C, Deschamps D, et al. (1995) Effects of female sex hormones on mitochondria: possible role in acute fatty liver of pregnancy. Am J Physiol 268, G107-G115.
37. Low YL, Dunning AM, Dowsett M, et al. (2007) Phytoestrogen exposure is associated with circulating sex hormone levels in postmenopausal women and interact with ESR1 and NR1I2 gene variants. Cancer Epidemiol Biomarkers Prev 16, 1009-1016.
38. Brooks JD & Thompson LU (2005) Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 94, 461-467.
39. Mueller SO, Simon S, Chae K, et al. (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80, 14-25.
40. Penttinen P, Jaehrling J, Damdimopoulos AE, et al. (2007) Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148, 4875-4886.
41. Prasad K (2000) Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 9, 220-225.
42. Bergman Jungestrom M, Thompson LU & Dabrosin C (2007) Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res 13, 1061-1067.
43. Sonestedt E & Wirfalt E (2010) Enterolactone and breast cancer: methodological issues may contribute to conflicting results in observational studies. Nutr Res 30, 667-677.
44. Qin N, Yang F, Li A, et al. (2014) Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59-64.